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Abstract 
Adsorption of bovine serum albumin (BSA) on nanosized magnetic particles (Fe3O4) was carried out by a chemical co-
precipitation procedure. Characterizations of magnetic particles were carried out using transmission electron microscopy (TEM), 
photon cross correlation spectroscopy (PCCS) and SQUID magnetometer. Fourier-transform infrared spectroscopy (FTIR) and 
differential scanning calorimetry (DSC) were used to confirm the attachment of BSA on magnetic particles with the stabilising 
surfactant. The effect of magnetic particles covered by BSA on the amyloid aggregation of the hen egg white lysozyme was 
investigated. The process of aggregation was followed in vitro by an assay based on the dyes Thioflavin T and 
8-anilinonaphthalene-1-sulfonic acid (ANS). We found that magnetic nanoparticles significantly reduced amyloid aggregation of 
lysozyme up to 70%. 
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1. Introduction 
 
Magnetic fluids (MFs) are colloidal suspensions of magnetic particles, with typical dimensions of about 10 nm, 
dispersed in a liquid carrier. They have many potential biomedical applications such as magnetic separation, cell 
labelling, targeted drug delivery, hyperthermia treatment of solid tumours and contrast agents for magnetic 
resonance imaging. In these applications, the magnetic particles need to be stable in aqueous solutions, what can be 
achieved by the modification of the surface of magnetic particles. Apart from the impact on the stabilization, 
modifying the surface properties of the particles is also used to determine their biocompatibility, their ability to be 
biodegraded and to reduce their toxicity. On the other hand, the choice of the coating layer is critical since the 
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coating process may change the particle size and result in the changing of superparamagnetic properties, which are 
considered to be the most important physical characteristic for the in vivo and in vitro application of MF. 
The coating layer formed by proteins can be important factor affecting the properties of nanoparticles. Serum 
albumin is the most abundant protein in the circulatory system, accounting for 60% of the total serum proteins. 
Serum albumin plays a key role in the transport of a large number of metabolites, endogenous ligands, fatty acids, 
bilirubin, hormones, anaesthetics, and commonly used drugs, which may be delivered to the appropriate cellular 
targets. Engineered nanoparticles could be potential drugs for controlling or curing of various diseases if designed to 
be biocompatible and biodegradable, and if safety issues can be addressed. 
     In the last few years, there has been an increasing interest in the study of the effect of nanoparticles on amyloid 
aggregation of proteins associated with many well-NQRZQLQFXUDEOHDP\ORLGGLVHDVHVVXFKDV$O]KHLPHU¶VGLVHDVH
3DUNLQVRQ¶VGLVHDVHW\SH,,GLDEHWHVRUYDULRXVIRUPVRIV\VWHPLFDP\ORLGRVLV>@5Hcent works have addressed the 
potential of nanoparticles to affect amyloid aggregation of proteins. The obtained data suggest that nanoparticles are 
able to prevent formation of protein amyloid aggregates as well as to promote the process of amyloid fibrillization. 
The objectives of this work were to prepare magnetic fluid containing bovine serum albumin (MFBSA), to 
characterize its morphology, size, magnetic properties, and to observe the interaction of MFBSA with protein 
lysozyme to find out its effect on the amyloid aggregation of proteins. 
 
2. Experiment and results 
 
The magnetic Fe3O4 particles were synthesized by a chemical co-precipitation procedure. Ferrous sulphate 
heptahydrate (FeSO4·7H2O) and ferric chloride hexahydrate (FeCl3·6H2O) with molar ratio of 1:2 were dissolved in 
deionised water under vigorous stirring. Then 25% v/v ammonium hydroxide (NH4OH) was added as a base source 
at room temperature until pH value of 11 was reached. The sediment obtained was washed for five times with 
deionised water to remove impurities. The stabilization of the magnetite precipitate was achieved by adding sodium 
oleate (C17H33COONa, theoretical ratio 1.1 g to 1.5 g of Fe3O4) during stirring and heating until the boiling point 
was reached. Then centrifugation at 9000 rpm during 30 min followed. The system at this stage is investigated 
below as initial ferrofluid and referred to as MF. Adsorption of BSA on MF was carried out by adding BSA (Mw = 
66 kDa) to the system. BSA was added in the form of 10 % w/v solution to a MF, while it was stirred and heated up 
to ca. 50 °C and then left to cool down to room temperature (MFBSA). BSA was used due to the high sequential 
homology of BSA (76 %) with human serum albumin (HSA). The added amount was 0.35 g of BSA per 1 g of 
Fe3O4. The stock solution of MFBSA had a magnetite content of 11 mg Fe3O4 /ml; the pH was 9.  
The average core diameter of magnetic particles was 12 nm, as deduced from the transmission electron 
micrograph (TEM), presented in Fig. 1a. Photon cross correlation spectroscopy (PCCS) was performed as an 
additional method to determine the particle size and distribution. Fig. 1b gives the PCCS results of both MF and 
MFBSA. It is evident that the hydrodynamic diameter was in the same range but it was larger than the size 
determined from TEM.  
Figure 1: a) TEM image of MFBSA (left) and b) the particle size distribution of MFBSA from PCCS measurement (right). 
 
The superparamagnetic properties of the magnetic particles were also verified by the magnetization curve 
measured by SQUID magnetometer. As expected, no hysteresis was observed, i.e. the magnetic particles were in a 
superparamagnetic regiment. The saturation magnetization of prepared MFBSA was 55 mT. 
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Figure 2: The collected FTIR spectra: a) BSA, b) MFBSA, c) washed MFBSA particles. The significant reduction of amide I band, marked with 
arrow, clearly demonstrates the decrease of BSA content. 
 
Fourier transform infrared (FTIR) spectroscopy with KBr pellet method was applied to detect BSA. The FTIR 
results are shown in Fig. 2. An interesting feature of the collected spectra was that they gave some notion about the 
interactions of BSA with the magnetic particles. The symmetric stretching of carboxylate group of BSA was 
observed at 1406 cm
-1
 in the spectrum of MFBSA, whereas this vibration was observed at 1396 cm
-1
 in the spectrum 
of pure BSA. This up-shifted carboxylate vibration suggests conformational changes of BSA during binding to the 
magnetic particles.     
The additional method suitable for the characterization of the adsorbed protein on magnetic particles is DSC. Fig. 
3 shows that BSA had a denaturation temperature Td = 58.5 
o
C. However, no obvious thermal transition was 
observed for the adsorbed BSA. This absence of the peak in the DSC curve is similar to the work of Peng et al. [2]. 
They pointed out that an apparent loss of thermal transition was not a sure indication of loss of native structure, 
because a loss of protein thermal transition at adsorbed condition had been shown with retaining large degree of 
structure, referring to Vermonden et al. [3]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: DSC traces of dried samples at a heating rate of 3oC/min: BSA, pure MF, MFBSA, and physical mixture of MF and BSA 
 
The ability of MFBSA to influence the amyloid aggregation in vitro was investigated for hen egg white lysozyme 
as prototypical amyloidogenic protein exploiting the fact that the ability to form amyloid aggregates is a generic 
property of proteins. The effect of magnetic fluid on lysozyme amyloid aggregation was detected by two 
independent spectroscopic methods ± Thioflavin T (ThT) assay and ANS assay (8-anilinonaphthalene-1-sulfonic 
acid). ThT assay is sensitive to the interaction between the dye and the ȕ-sheets of the amyloids. ANS is commonly 
utilized as a probe for conformational properties and solvent exposure of the hydrophobic surfaces in proteins [4]. 
For both methods, presence of lysozyme amyloid aggregates (Lagg) is associated with significant increase of 
fluorescence intensity, which is not observed for native protein (Lnat) (Fig. 4) or amorphous aggregates. As the 
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fluorescence is proportional to the amount of the amyloids, the lowering of the fluorescence signal indicates a 
decrease of lysozyme amyloid aggregation. The extent of lysozyme aggregation was observed after overnight 
incubation of the MFBSA (0.294 mg Fe3O4POZLWKO\VR]\PHDP\ORLGV/DJJȝ0PJPOExpressive 
declines of the fluorescence intensities were detected by both ThT and ANS assays (Fig. 4).  The presence of 
MFBSA caused about 60% ThT and 70% ANS fluorescence decrease in comparison for that observed for amyloid 
aggregates. The obtained results suggest that MFBSA had significant ability to depolymerise amyloid aggregates of 
lysozyme. 
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Figure 4: Fluorescence intensities of the native lysozyme (Lnat), lysozyme amyloid aggregates (Lagg) and lysozyme amyloids after overnight 
incubation with MFBSA (Lagg:MFBSA = 1:2) observed by ThT and ANS assays. The data are normalized to the fluorescence signal observed 
for lysozyme amyloid aggregates (take as 100%). 
 
3. Conclusions 
 
A BSA containing magnetic fluid was prepared by a chemical precipitation method and characterized by TEM, 
PCCS and SQUID for size and superparamagnetic properties. FTIR spectra and DSC thermograms were used to 
confirm the attachment of BSA on the magnetic particles. The incubation of lysozyme amyloid aggregates with 
MFBSA led to a significant decrease of the amount of protein in amyloid state up to 70%. This finding makes 
MFBSA of potential interest as a therapeutic agent against amyloid diseases. 
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